g ‘I’d like a packet of ibuprofen’, yet this type of consultatio

g. ‘I’d like a packet of ibuprofen’, yet this type of consultation occurs most this website frequently.[7] Conversely, consultations that involve greater

communication between the patient and staff member, such as advice requests, e.g. ‘I need something for thrush’, are more likely to result in more counselling behaviour and an appropriate outcome.[1] A systematic review of communication between patients and health professionals about medicine taking and prescribing in general,[8] found that few patients ask pharmacists (or pharmacy staff) about their medicines, with one of the reasons being that they lack awareness about which questions they could or should ask. Most patients did not expect to be questioned when purchasing a NPM, but agreed that it was important for pharmacy staff to ask about the condition for which R428 chemical structure they were buying the medicine, and who would be using

the medicine.[8] A linguistic analysis of consultations for NPMs confirmed that patients provide information when asked for it, but this relies upon pharmacy staff asking the relevant questions.[9] In the UK, most consultations for NPMs are dealt with by medicine counter assistants (MCAs)[1] who are trained members of the pharmacy team. In the early 1990s, a mnemonic called ‘WWHAM’ was introduced to promote more structured information gathering during consultations for NPMs.[10] WWHAM refers to Who is the medicine for?; What are the symptoms?; How long have the symptoms been present?; Any other medication tried?; and

other Medication currently used? Similar frameworks are used in other countries. Much of the empirical research by Watson et al.,[11] which informed this current study explored the use of WWHAM[11] and a positive association was shown between the extent of counselling and the number of WWHAM questions asked or elicited and the likelihood of Depsipeptide manufacturer an appropriate outcome.[11] Interventions are needed to promote better communication between patients and pharmacy staff during consultations for NPMs and thus improve outcome. However, without knowing the key factors that influence patient communication during these consultations, a systematic approach to intervention development and evaluation would not be possible. For example, interventions could be developed to target patient knowledge about medicines, but if knowledge was not the major factor involved in sharing information during these consultations, the intervention would be ineffective. The value of having an explicit, evidence-based theoretical model has been emphasised in the Medical Research Council (MRC) Framework for the development of complex interventions.[12, 13] This incremental approach to development and evaluation is effective and efficient in targeting interventions at behaviours or factors that are most likely to result in the desired outcome.

Related posts:

  1. 9, p  70 001) or elderly wards (from 60% to 73%; χ2=22 4, p<0 001
  2. 3 years in patients wild type for both Our cohort included 22 pa
  3. These include small group discussions/seminars, student interview
  4. GSK1838705A of phosphodiesterase type 5 Prostacyclin analogs are not known
  5. The GMC guidance document ‘Tomorrow’s Doctors’ and the GPhC’s ‘Fu
This entry was posted in Antibody. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>